Compare CLOV & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLOV | STAA |
|---|---|---|
| Founded | 2014 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2020 | 1995 |
| Metric | CLOV | STAA |
|---|---|---|
| Price | $4.98 | $29.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $2.90 | ★ $22.81 |
| AVG Volume (30 Days) | ★ 8.9M | 640.9K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.03 | N/A |
| EPS | 0.05 | ★ 0.10 |
| Revenue | ★ $1,924,308,000.00 | $239,442,000.00 |
| Revenue This Year | $52.59 | $30.82 |
| Revenue Next Year | $15.37 | $8.41 |
| P/E Ratio | ★ $99.90 | $288.85 |
| Revenue Growth | ★ 40.34 | N/A |
| 52 Week Low | $1.58 | $15.59 |
| 52 Week High | $5.18 | $35.87 |
| Indicator | CLOV | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 73.54 | 50.23 |
| Support Level | $1.96 | $28.03 |
| Resistance Level | $5.18 | $31.05 |
| Average True Range (ATR) | 0.29 | 1.00 |
| MACD | 0.05 | -0.28 |
| Stochastic Oscillator | 90.03 | 36.09 |
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.